New

IDONTRAX^® range

Ready-to-use dPCR assays

Simultaneous detection of mutations in cDNA and DNA

Optimized for

Digital LightCycler^® System

EASY TO USE

Ready-to-use mix of probes and primers.
Up to 23 targets in a single reaction

FAST

Results in
less than 4 hours

RELIABLE

Target controls included

PRECISE

ID SOLUTIONS
Patented technology*

OPTIMIZED

Tested on the Digital LightCycler^® System

Reliable and reproducible tests

The IDONTRAX range comprises qPCR tests dedicated to the detection of somatic mutations in oncology, designed for optimal use on Roche’s LightCycler System. IDONTRAX combines analytical performance, ease of use and standardisation to support molecular biology laboratories in their decision-making analyses.

Accurate detection of mutations

With the IDONTRAX range, mutation detection becomes more accurate and reliable. Based on digital PCR (dPCR), IDONTRAX technology reliably identifies key mutations, even when they are present in very low abundance. Each test is designed to finely discriminate between mutated alleles and wild-type alleles, ensuring clear, actionable and reproducible results.

Optimised for ease of use, the reagents include a target process control (TPC). This allows for more accurate results. The use of the ID-ICE reagent allows for good control of the pre-analytical process. This enhances the reliability of the results.

A range optimised for Digital LightCycler^® system

IDONTRAX tests have been developed and validated for optimal compatibility with the Digital LightCycler® platform.

Excellent fluorescence signal stability
Adapted thermal profiles
High inter-run reproducibility
Seamless integration into existing qPCR workflows

This instrumental optimisation allows for rapid implementation without complex modifications to laboratory protocols.

Explore our catalog of innovative digital PCR assays

IDONTRAX^® H3F3A

Primers and Probes set for H3F3A mutations detection

IDONTRAX^® BRAF-CNS

Primers and Probes set for BRAF mutations detection

IDONTRAX^® EGFR SENSI

Primers and Probes set for EGFR mutations detection

IDONTRAX^® EGFR RESIST

Primers and Probes set for EGFR mutations detection

IDONTRAX^® KRAS G12C

Primers and Probes set for KRAS G12C mutation detection

IDONTRAX^® KRAS 3X

Primers and Probes set for KRAS mutations detection on exon 2, 3 and 4

IDONTRAX^® BRAF

Primers and Probes set for BRAF mutations detection

IDONTRAX^® ESR1

Primers and Probes set for ESR1 mutations detection

IDONTRAX^® TERT

Primers and Probes set for TERT mutations detection

IDONTRAX^® FGFR1-CNS

Primers and Probes set for FGFR1 mutations detection and Exons 11 to 18 duplication detection

IDONTRAX^® PIK3CA

Primers and Probes set for PIK3CA mutations detection

IDONTRAX^® NRAS

Primers and Probes set for NRAS mutations detection

G12S, G12R, G12C, G12N, G12P, G12Y, G12D, G12A, G12V, G12E, G13S, G13R, G13C, G13N, G13Y, G13F, G13D, G13A, G13V, G60_Q61insAS, Q61E, Q61P, Q61R, Q61L, Q61H, Q61_E62>HK
Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
96 tests

IDONTRAX^® IDH1-2

Primers and Probes set for IDH1 and IDH2 mutations detection

IDONTRAX mMLH1

Quantification of the methylation rate of the MLH1 promoter

Associated products

ID-ICE

Internal control of extraction

IDNAPTEX EGFR RESIST

Système de distinction des mutations du gène BRAF dans le système nerveux central

^{*ID-ICE can be ordered separately. The patented ID SOLUTIONS technology is protected in Europe by patent number EP 3565902 and in the United States by patent number 12049664.}

^{Trademarks: Digital LightCycler. The registered names, trademarks, etc. used in this document, even if not specifically marked as such, may be protected by law.}

^{ID SOLUTIONS and IDONTRAX are registered trademarks of ID SOLUTIONS.}

IDONTRAX^® range

Ready-to-use dPCR assays

Simultaneous detection of mutations in cDNA and DNA